RIGL
Rigel Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
RIGL fundamentals
During Q4 2025, Rigel Pharmaceuticals (RIGL) reported revenue of 69.80M, a YoY change of 21.19%. Net income was 268.06M, a YoY change of 1769.22%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q2,2015 | Q3,2015 | Q4,2015 | Q1,2016 | Q2,2016 | Q3,2016 | Q4,2016 | Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Apr 1, 2015 | Jul 1, 2015 | Oct 1, 2015 | Jan 1, 2016 | Apr 1, 2016 | Jul 1, 2016 | Oct 1, 2016 | Jan 1, 2017 | Apr 1, 2017 | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Jun 30, 2015 | Sep 30, 2015 | Dec 31, 2015 | Mar 31, 2016 | Jun 30, 2016 | Sep 30, 2016 | Dec 31, 2016 | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 5.18M -- | 13.00M -- | 8.54M -- | 5.03M -- | 8.59M +65.78% | 3.76M -71.07% | 3.00M -64.86% | 3.58M -28.73% | -- -- | 900.00K -76.06% | 0 -100.00% | -- -- | 1.79M -- | 4.87M +440.56% | 37.86M -- | 12.62M -- | 10.41M +482.37% | 20.86M +328.72% | 15.40M -59.32% | 55.76M +341.71% | 16.02M +53.94% | 18.39M -11.83% | 18.45M +19.81% | 81.02M +45.30% | 26.27M +63.95% | 21.54M +17.15% | 20.41M +10.62% | 16.73M -79.34% | 29.82M +13.53% | 22.41M +4.02% | 51.28M +151.25% | 26.07M +55.78% | 26.89M -9.84% | 28.13M +25.54% | 35.79M -30.20% | 29.53M +13.29% | 36.84M +37.03% | 55.31M +96.58% | 57.60M +60.92% | 53.33M +80.58% | 101.69M +176.01% | 69.46M +25.59% | 69.80M +21.19% | 294.28M -- |
Sales and Services Revenue | 5.18M -- | 13.00M -- | 8.54M -- | 5.03M -- | 8.59M +65.78% | 3.76M -71.07% | 3.00M -64.86% | 3.58M -28.73% | -- -- | 900.00K -76.06% | 0 -100.00% | -- -- | 1.79M -- | 4.87M +440.56% | 37.86M -- | 12.62M -- | 10.41M +482.37% | 20.86M +328.72% | 15.40M -59.32% | 55.76M +341.71% | 16.02M +53.94% | 18.39M -11.83% | 18.45M +19.81% | 81.02M +45.30% | 26.27M +63.95% | 21.54M +17.15% | 20.41M +10.62% | 16.73M -79.34% | 29.82M +13.53% | 22.41M +4.02% | 51.28M +151.25% | 26.07M +55.78% | 26.89M -9.84% | 28.06M +25.21% | 35.87M -30.05% | 26.00M -0.26% | 33.45M +24.41% | 55.31M +97.11% | 57.60M +60.58% | 43.55M +67.48% | 58.95M +76.23% | 69.46M +25.59% | 69.80M +21.19% | 241.76M -- |
Other Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 75.00K -- | -75.00K -- | 3.53M -- | 3.39M -- | -- -- | -- -- | 9.78M +177.06% | 42.74M +1160.31% | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 30.00K -- | 69.00K -- | 188.00K -- | 107.00K -- | 311.00K +936.67% | 310.00K +349.28% | 178.00K -5.32% | 155.00K +44.86% | 279.00K -10.29% | 140.00K -54.84% | 321.00K +80.34% | 316.00K +103.87% | 129.00K -53.76% | 151.00K +7.86% | 487.00K +51.71% | 121.00K -61.71% | 1.04M +703.10% | 250.00K +65.56% | 342.00K -29.77% | 977.00K +707.44% | 1.07M +3.76% | 1.27M +407.20% | 3.79M +1008.19% | 2.02M +107.27% | 2.81M +161.12% | 8.03M +532.97% | 5.79M +52.74% | 4.41M +117.73% | 4.50M +60.46% | 4.75M -40.78% | 5.96M +2.87% | 19.62M -- |
Cost of Goods and Services | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 287.00K -- | -- -- | -- -- | -- -- | 906.00K +215.68% | -- -- | -- -- | -- -- | 895.00K -1.21% | -- -- | -- -- | -- -- | 1.08M +21.01% | -- -- | -- -- | -- -- | 1.75M +61.50% | -- -- | -- -- | 1.27M -- | 3.79M +116.70% | 2.02M -- | 2.81M -- | 8.03M +532.97% | 5.79M +52.74% | 4.41M +117.73% | 4.50M +60.46% | 4.75M -40.78% | 5.96M +2.87% | 19.62M -- |
Gross Profit | 5.18M -- | 13.00M -- | 8.54M -- | 5.03M -- | 8.59M +65.78% | 3.76M -71.07% | 3.00M -64.86% | 3.58M -28.73% | -- -- | 900.00K -76.06% | 0 -100.00% | -- -- | 1.76M -- | 4.80M +432.89% | 37.67M -- | 12.52M -- | 10.10M +474.62% | 20.55M +328.42% | 15.22M -59.59% | 55.61M +344.24% | 15.74M +55.92% | 18.25M -11.18% | 18.13M +19.10% | 80.70M +45.13% | 26.14M +66.03% | 21.39M +17.22% | 19.92M +9.89% | 16.61M -79.41% | 28.78M +10.12% | 22.16M +3.59% | 50.94M +155.68% | 25.09M +51.04% | 25.81M -10.33% | 26.87M +21.24% | 32.00M -37.17% | 27.51M +9.63% | 34.03M +31.86% | 47.28M +75.99% | 51.81M +61.89% | 48.92M +77.85% | 97.18M +185.54% | 64.71M +36.86% | 63.85M +23.24% | 274.66M -- |
Operating Expenses | 19.16M -- | 19.78M -- | 21.28M -- | 22.60M -- | 22.24M +16.10% | 26.50M +33.99% | 18.79M -11.73% | 19.79M -12.44% | 19.34M -13.03% | 18.75M -29.22% | 26.21M +39.54% | 24.73M +25.01% | 27.87M +44.07% | 29.17M +55.51% | 35.14M +34.03% | 30.89M +24.91% | 31.43M +12.80% | 32.58M +11.72% | 32.56M -7.34% | 34.58M +11.92% | 33.13M +5.40% | 32.03M -1.70% | 36.96M +13.50% | 38.95M +12.63% | 39.19M +18.26% | 41.18M +28.56% | 41.34M +11.86% | 42.88M +10.09% | 41.75M +6.54% | 40.56M -1.49% | 48.86M +18.18% | 37.82M -11.79% | 31.08M -25.56% | 31.33M -22.76% | 30.04M -38.52% | 34.48M -8.84% | 33.59M +8.07% | 33.23M +6.05% | 35.15M +17.03% | 36.15M +4.86% | 36.08M +7.42% | 36.29M +9.22% | 40.68M +15.72% | 149.19M -- |
Selling, General and Administrative Expenses | 4.10M -- | 4.28M -- | 4.72M -- | 4.42M -- | 4.77M +16.47% | 4.56M +6.59% | 7.15M +51.51% | 7.41M +67.53% | 7.82M +63.80% | 7.95M +74.35% | 14.65M +104.87% | 13.49M +82.08% | 17.07M +118.30% | 18.07M +127.37% | 21.37M +45.83% | 19.95M +47.84% | 18.21M +6.67% | 18.12M +0.29% | 18.31M -14.31% | 18.43M -7.60% | 18.92M +3.90% | 17.43M -3.81% | 21.82M +19.15% | 22.12M +20.03% | 22.38M +18.28% | 22.88M +31.25% | 24.52M +12.36% | 27.40M +23.87% | 26.98M +20.57% | 25.90M +13.20% | 32.17M +31.23% | 27.73M +1.20% | 26.31M -2.50% | 24.86M -4.02% | 26.85M -16.54% | 28.45M +2.60% | 28.05M +6.62% | 27.04M +8.80% | 29.52M +9.94% | 27.71M -2.58% | 29.26M +4.31% | 28.94M +7.00% | 29.99M +1.60% | 115.90M -- |
Research and Development Expenses | 15.06M -- | 15.50M -- | 16.56M -- | 18.17M -- | 17.47M +16.00% | 16.17M +4.32% | 11.63M -29.76% | 12.38M -31.90% | 11.52M -34.03% | 10.81M -33.16% | 11.56M -0.63% | 11.24M -9.16% | 10.80M -6.31% | 11.10M +2.67% | 13.77M +19.08% | 10.95M -2.61% | 13.23M +22.50% | 14.46M +30.33% | 14.25M +3.49% | 16.15M +47.49% | 14.21M +7.47% | 14.60M +0.95% | 15.14M +6.25% | 16.83M +4.19% | 16.81M +18.24% | 18.30M +25.34% | 13.30M -12.12% | 15.47M -8.04% | 14.77M -12.14% | 14.67M -19.86% | 15.37M +15.49% | 10.09M -34.80% | 4.77M -67.68% | 6.47M -55.85% | 3.19M -79.26% | 6.03M -40.27% | 5.54M +16.09% | 6.18M -4.53% | 5.63M +76.77% | 8.44M +39.99% | 6.82M +23.12% | 7.35M +18.94% | 10.69M +89.72% | 33.30M -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 3.52M -- | -- -- | -- -- | -- -- | 1.32M -62.51% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | 5.77M -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -13.97M -- | -6.78M -- | -12.75M -- | -17.57M -- | -13.65M +2.33% | -22.74M -235.33% | -15.79M -23.85% | -16.20M +7.77% | -19.34M -41.74% | -17.86M +21.48% | -26.21M -66.05% | -24.73M -52.66% | -26.11M -34.98% | -24.37M -36.49% | 2.53M +109.66% | -18.38M +25.70% | -21.34M +18.28% | -12.04M +50.61% | -17.34M -784.72% | 21.03M +214.41% | -17.39M +18.50% | -13.78M -14.49% | -18.83M -8.59% | 41.76M +98.58% | -13.05M +24.98% | -19.79M -43.57% | -21.42M -13.76% | -26.26M -162.89% | -12.96M +0.64% | -18.40M +6.99% | 2.08M +109.71% | -12.72M +51.54% | -5.27M +59.38% | -4.46M +75.74% | 1.97M -5.44% | -6.97M +45.26% | 447.00K +108.49% | 14.06M +414.80% | 16.66M +747.15% | 12.77M +283.36% | 61.10M +13569.57% | 28.42M +102.19% | 23.17M +39.12% | 125.47M -- |
Non-Operating Income (Loss) | 62.00K -- | 109.00K -- | 60.00K -- | 103.00K -- | 115.00K +85.48% | 110.00K +0.92% | 197.00K +228.33% | 888.00K +762.14% | 197.00K +71.30% | 195.00K +77.27% | 344.00K +74.62% | 349.00K -60.70% | 554.00K +181.22% | 604.00K +209.74% | 696.00K +102.33% | 780.00K +123.50% | 733.00K +32.31% | 547.00K -9.44% | 137.00K -80.32% | 216.00K -72.31% | -184.00K -125.10% | -393.00K -171.85% | -410.00K -399.27% | -484.00K -324.07% | -1.74M -847.28% | -1.30M -231.55% | -1.28M -212.93% | -1.18M -144.63% | -527.00K +69.76% | -634.00K +51.34% | -678.00K +47.16% | -811.00K +31.50% | -1.33M -152.94% | -1.23M -93.53% | -1.23M -81.27% | -1.28M -57.95% | -1.48M -10.80% | -1.64M -33.25% | -1.43M -16.60% | -1.26M +1.48% | -1.12M +24.10% | -800.00K +51.07% | -456.00K +68.18% | -3.64M -- |
Other Non-Operating Income (Loss) | -- -- | 55.00K -- | 0 -- | -- -- | -- -- | -- -- | 88.00K -- | 732.00K -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Interest Expense | -62.00K -- | -54.00K -- | -60.00K -- | -103.00K -- | -115.00K -85.48% | -110.00K -103.70% | -109.00K -81.67% | -156.00K -51.46% | -197.00K -71.30% | -195.00K -77.27% | -344.00K -215.60% | -349.00K -123.72% | -554.00K -181.22% | -604.00K -209.74% | -696.00K -102.33% | -780.00K -123.50% | -733.00K -32.31% | -547.00K +9.44% | -137.00K +80.32% | -216.00K +72.31% | 184.00K +125.10% | 393.00K +171.85% | 410.00K +399.27% | 484.00K +324.07% | 1.74M +847.28% | 1.30M +231.55% | 1.28M +212.93% | 1.18M +144.63% | 527.00K -69.76% | 634.00K -51.34% | 678.00K -47.16% | 811.00K -31.50% | 1.33M +152.94% | 1.23M +93.53% | 1.23M +81.27% | 1.28M +57.95% | 1.48M +10.80% | 1.64M +33.25% | 1.43M +16.60% | 1.26M -1.48% | 1.12M -24.10% | 800.00K -51.07% | 456.00K -68.18% | 3.64M -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 8.00K -- | 327.00K -- | 142.00K -- | 353.00K -- | 429.00K +5262.50% | 429.00K +31.19% | 485.00K +241.55% | 1.76M +398.30% | 1.32M +206.99% | 1.30M +202.80% | 1.21M +148.45% | 569.00K -67.65% | 826.00K -37.28% | 1.11M -14.78% | 1.20M -0.08% | 1.86M +227.24% | 1.90M +129.90% | 1.91M +72.27% | 1.87M +55.65% | 2.03M +8.97% | 2.06M +8.48% | 1.96M +2.52% | 1.85M -1.12% | 1.87M -7.64% | 1.89M -8.06% | 1.70M -13.09% | 7.32M -- |
Interest Income | 62.00K -- | 54.00K -- | 60.00K -- | 103.00K -- | 115.00K +85.48% | 110.00K +103.70% | 109.00K +81.67% | 156.00K +51.46% | 197.00K +71.30% | 195.00K +77.27% | 344.00K +215.60% | 349.00K +123.72% | 554.00K +181.22% | 604.00K +209.74% | 696.00K +102.33% | 780.00K +123.50% | 733.00K +32.31% | 555.00K -8.11% | 464.00K -33.33% | 358.00K -54.10% | 169.00K -76.94% | 36.00K -93.51% | 19.00K -95.91% | 1.00K -99.72% | 16.00K -90.53% | 14.00K -61.11% | 16.00K -15.79% | 21.00K +2000.00% | 42.00K +162.50% | 192.00K +1271.43% | 429.00K +2581.25% | 393.00K +1771.43% | 529.00K +1159.52% | 672.00K +250.00% | 678.00K +58.04% | 593.00K +50.89% | 552.00K +4.35% | 425.00K -36.76% | 522.00K -23.01% | 591.00K -0.34% | 753.00K +36.41% | 1.09M +157.41% | 1.24M +138.12% | 3.68M -- |
Pretax Income From Continuing Operations | -13.91M -- | -6.67M -- | -12.69M -- | -17.46M -- | -13.53M +2.72% | -22.63M -239.16% | -15.59M -22.88% | -15.31M +12.31% | -19.15M -41.48% | -17.66M +21.96% | -25.87M -65.95% | -24.39M -59.23% | -25.56M -33.48% | -23.77M -34.58% | 3.23M +112.48% | -17.60M +27.83% | -20.61M +19.37% | -11.49M +51.65% | -17.20M -632.84% | 21.24M +220.71% | -17.58M +14.70% | -14.17M -23.36% | -19.24M -11.84% | 41.27M +94.28% | -14.79M +15.85% | -21.09M -48.78% | -22.70M -18.01% | -27.45M -166.50% | -13.49M +8.78% | -19.04M +9.73% | 1.40M +106.17% | -13.54M +50.68% | -6.60M +51.08% | -5.69M +70.10% | 737.00K -47.39% | -8.25M +39.07% | -1.03M +84.39% | 12.42M +318.22% | 15.22M +1965.40% | 11.51M +239.58% | 59.98M +5923.50% | 27.62M +122.37% | 22.71M +49.22% | 121.83M -- |
Income Tax Expense | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 1.77M -- | -970.00K -- | -136.00K -- | -60.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 881.00K -- | 65.00K -- | 369.00K -- | -280.00K -- | -245.35M -27949.15% | -245.20M -- |
Current Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 881.00K -- | -- -- | -- -- | -- -- | 655.00K -25.65% | -- -- |
Deferred Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -245.85M -- | -- -- |
Net Income | -13.91M -- | -6.67M -- | -12.69M -- | -17.46M -- | -13.53M +2.72% | -22.63M -239.16% | -15.59M -22.88% | -15.31M +12.31% | -19.15M -41.48% | -17.66M +21.96% | -25.87M -65.95% | -24.39M -59.23% | -25.56M -33.48% | -23.77M -34.58% | 3.23M +112.48% | -17.60M +27.83% | -20.61M +19.37% | -11.49M +51.65% | -17.20M -632.84% | 21.24M +220.71% | -17.58M +14.70% | -14.17M -23.36% | -19.24M -11.84% | 39.50M +85.94% | -13.82M +21.36% | -20.95M -47.82% | -22.64M -17.70% | -27.45M -169.48% | -13.49M +2.38% | -19.04M +9.14% | 1.40M +106.19% | -13.54M +50.68% | -6.60M +51.08% | -5.69M +70.10% | 737.00K -47.39% | -8.25M +39.07% | -1.03M +84.39% | 12.42M +318.22% | 14.34M +1845.86% | 11.45M +238.79% | 59.61M +5887.67% | 27.90M +124.62% | 268.06M +1769.22% | 367.02M -- |
Net Income Attributable to Owners of the Company | -13.91M -- | -6.67M -- | -12.69M -- | -17.46M -- | -13.53M +2.72% | -22.63M -239.16% | -15.59M -22.88% | -15.31M +12.31% | -19.15M -41.48% | -17.66M +21.96% | -25.87M -65.95% | -24.39M -59.23% | -25.56M -33.48% | -23.77M -34.58% | 3.23M +112.48% | -17.60M +27.83% | -20.61M +19.37% | -11.49M +51.65% | -17.20M -632.84% | 21.24M +220.71% | -17.58M +14.70% | -14.17M -23.36% | -19.24M -11.84% | 39.50M +85.94% | -13.82M +21.36% | -20.95M -47.82% | -22.64M -17.70% | -27.45M -169.48% | -13.49M +2.38% | -19.04M +9.14% | 1.40M +106.19% | -13.54M +50.68% | -6.60M +51.08% | -5.69M +70.10% | 737.00K -47.39% | -8.25M +39.07% | -1.03M +84.39% | 12.42M +318.22% | 14.34M +1845.86% | 11.45M +238.79% | 59.61M +5887.67% | 27.90M +124.62% | 268.06M +1769.22% | 367.02M -- |
Net Income Attributable to Common Stockholders | -13.91M -- | -6.67M -- | -12.69M -- | -17.46M -- | -13.53M +2.72% | -22.63M -239.16% | -15.59M -22.88% | -15.31M +12.31% | -19.15M -41.48% | -17.66M +21.96% | -25.87M -65.95% | -24.39M -59.23% | -25.56M -33.48% | -23.77M -34.58% | 3.23M +112.48% | -17.60M +27.83% | -20.61M +19.37% | -11.49M +51.65% | -17.20M -632.84% | 21.24M +220.71% | -17.58M +14.70% | -14.17M -23.36% | -19.24M -11.84% | 39.50M +85.94% | -13.82M +21.36% | -20.95M -47.82% | -22.64M -17.70% | -27.45M -169.48% | -13.49M +2.38% | -19.04M +9.14% | 1.40M +106.19% | -13.54M +50.68% | -6.60M +51.08% | -5.69M +70.10% | 737.00K -47.39% | -8.25M +39.07% | -1.03M +84.39% | 12.42M +318.22% | 14.34M +1845.86% | 11.45M +238.79% | 59.61M +5887.67% | 27.90M +124.62% | 268.06M +1769.22% | 367.02M -- |
Other Comprehensive Income | -6.00K -- | 14.00K -- | -69.00K -- | 93.00K -- | 4.00K +166.67% | -44.00K -414.29% | -27.00K +60.87% | -11.00K -111.83% | 10.00K +150.00% | 12.00K +127.27% | -75.00K -177.78% | -5.00K +54.55% | 38.00K +280.00% | 24.00K +100.00% | 1.00K +101.33% | 34.00K +780.00% | 33.00K -13.16% | -7.00K -129.17% | -13.00K -1400.00% | 55.00K +61.76% | -32.00K -196.97% | -44.00K -528.57% | -6.00K +53.85% | 3.00K -94.55% | 8.00K +125.00% | 1.00K +102.27% | -110.00K -1733.33% | -314.00K -10566.67% | -22.00K -375.00% | 152.00K +15100.00% | 133.00K +220.91% | 126.00K +140.13% | 2.00K +109.09% | 10.00K -93.42% | 23.00K -82.71% | -13.00K -110.32% | -4.00K -300.00% | 20.00K +100.00% | -1.00K -104.35% | -12.00K +7.69% | 8.00K +300.00% | 90.00K +350.00% | 85.00K +8600.00% | 171.00K -- |
Total Comprehensive Income | -13.92M -- | -6.66M -- | -12.76M -- | -17.37M -- | -13.53M +2.79% | -22.67M -240.54% | -15.62M -22.43% | -15.32M +11.78% | -19.14M -41.45% | -17.65M +22.16% | -25.95M -66.14% | -24.39M -59.15% | -25.52M -33.35% | -23.74M -34.53% | 3.23M +112.45% | -17.56M +27.99% | -20.57M +19.38% | -11.50M +51.58% | -17.21M -633.08% | 21.30M +221.26% | -17.61M +14.41% | -14.22M -23.67% | -19.24M -11.79% | 39.50M +85.48% | -13.81M +21.55% | -20.95M -47.36% | -22.75M -18.23% | -27.76M -170.27% | -13.51M +2.16% | -18.89M +9.86% | 1.53M +106.74% | -13.41M +51.69% | -6.60M +51.18% | -5.68M +69.91% | 760.00K -50.46% | -8.26M +38.40% | -1.03M +84.33% | 12.44M +318.95% | 14.34M +1786.84% | 11.43M +238.43% | 59.62M +5866.05% | 27.99M +124.98% | 268.15M +1769.94% | 367.19M -- |
Total Comprehensive Income Attributable to Owners of the Company | -13.92M -- | -6.66M -- | -12.76M -- | -17.37M -- | -13.53M +2.79% | -22.67M -240.54% | -15.62M -22.43% | -15.32M +11.78% | -19.14M -41.45% | -17.65M +22.16% | -25.95M -66.14% | -24.39M -59.15% | -25.52M -33.35% | -23.74M -34.53% | 3.23M +112.45% | -17.56M +27.99% | -20.57M +19.38% | -11.50M +51.58% | -17.21M -633.08% | 21.30M +221.26% | -17.61M +14.41% | -14.22M -23.67% | -19.24M -11.79% | 39.50M +85.48% | -13.81M +21.55% | -20.95M -47.36% | -22.75M -18.23% | -27.76M -170.27% | -13.51M +2.16% | -18.89M +9.86% | 1.53M +106.74% | -13.41M +51.69% | -6.60M +51.18% | -5.68M +69.91% | 760.00K -50.46% | -8.26M +38.40% | -1.03M +84.33% | 12.44M +318.95% | 14.34M +1786.84% | 11.43M +238.43% | 59.62M +5866.05% | 27.99M +124.98% | 268.15M +1769.94% | 367.19M -- |
Basic EPS | -0.16 -- | -0.08 -- | -- -- | -0.19 -- | -0.15 +6.25% | -0.24 -200.00% | -0.16 -- | -0.13 +31.58% | -0.16 -6.67% | -0.14 +41.67% | -0.18 -12.50% | -0.17 -30.77% | -0.16 -- | -0.14 -- | 0.02 +111.11% | -0.11 +35.29% | -0.12 +25.00% | -0.07 +50.00% | -0.1 -600.00% | 0.13 +218.18% | -0.1 +16.67% | -0.08 -14.29% | -0.11 -10.00% | 0.23 +76.92% | -0.08 +20.00% | -0.12 -50.00% | -0.13 -18.18% | -0.16 -169.57% | -0.08 -- | -0.11 +8.33% | 0.01 +107.69% | -0.08 +50.00% | -0.38 -375.00% | -0.33 -200.00% | 0 -100.00% | -0.47 -487.50% | -0.06 +84.21% | 0.71 +315.15% | 0.81 -- | 0.64 +236.17% | 3.33 +5650.00% | 1.55 +118.31% | 14.64 +1707.41% | 20.16 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.33 -- | -- -- | -0.47 -- | -0.06 -- | 0.71 +315.15% | -- -- | 0.64 +236.17% | 3.33 +5650.00% | 1.55 +118.31% | -- -- | -- -- |
Diluted EPS | -0.16 -- | -0.08 -- | -- -- | -0.19 -- | -0.15 +6.25% | -0.24 -200.00% | -- -- | -0.13 +31.58% | -0.16 -6.67% | -0.14 +41.67% | -- -- | -0.17 -30.77% | -0.16 -- | -0.14 -- | -- -- | -0.11 +35.29% | -0.12 +25.00% | -0.07 +50.00% | -- -- | 0.13 +218.18% | -0.1 +16.67% | -0.08 -14.29% | -- -- | 0.22 +69.23% | -0.08 +20.00% | -0.12 -50.00% | -- -- | -0.16 -172.73% | -0.08 -- | -0.11 +8.33% | -- -- | -0.08 +50.00% | -0.38 -375.00% | -0.33 -200.00% | -- -- | -0.47 -487.50% | -0.06 +84.21% | 0.7 +312.12% | -- -- | 0.63 +234.04% | 3.28 +5566.67% | 1.46 +108.57% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.33 -- | -- -- | -0.47 -- | -0.06 -- | 0.7 +312.12% | -- -- | 0.63 +234.04% | 3.28 +5566.67% | 1.46 +108.57% | -- -- | -- -- |
You can ask Aime
What guidance did Rigel Pharmaceuticals's management provide for the next earnings period?What were the key takeaways from Rigel Pharmaceuticals's earnings call?Did Rigel Pharmaceuticals beat or miss consensus estimates last quarter?What is Rigel Pharmaceuticals's latest dividend and current dividend yield?What is Rigel Pharmaceuticals's gross profit margin?What does Rigel Pharmaceuticals do and what are its main business segments?What factors drove the changes in Rigel Pharmaceuticals's revenue and profit?What were the key takeaways from Rigel Pharmaceuticals’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
